DNA methyltransferase inhibitors: catalysts for antitumour immune responses
H Dan, S Zhang, Y Zhou, Q Guan - OncoTargets and therapy, 2019 - Taylor & Francis
… In recent years, the epigenetic therapies used in cancer have made significant progress,
mainly due to the rapid development of genome-wide high-throughput sequencing technology. …
mainly due to the rapid development of genome-wide high-throughput sequencing technology. …
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
Y Lu, YT Chan, HY Tan, S Li, N Wang, Y Feng - Molecular cancer, 2020 - Springer
… Epigenetic treatment may therefore benefit cancer patients … and a combinatory treatment
with other current therapy. In this … DNA methylation is the most extensively studied epigenetic …
with other current therapy. In this … DNA methylation is the most extensively studied epigenetic …
Site-specific DNA demethylation as a potential target for cancer epigenetic therapy
SA Neja - Epigenetics insights, 2020 - journals.sagepub.com
… DNA methyltransferase inhibitors have been approved as first-generation epigenetic inhibitors
for cancer therapy… knowing the status of DNA methylation as with DNA epigenetic mark, 5-…
for cancer therapy… knowing the status of DNA methylation as with DNA epigenetic mark, 5-…
An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs
… examined for their anti-cancer or therapeutic effects on neurological diseases. Three main
epigenetic treatments are in a reliable consideration: DNMT and HDAC inhibitors and miRNA-…
epigenetic treatments are in a reliable consideration: DNMT and HDAC inhibitors and miRNA-…
Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
Y Su, NR Hopfinger, TD Nguyen, TJ Pogash… - … & Clinical Cancer …, 2018 - Springer
… in TNBC cells partially by epigenetically reprograming EMT. Our findings strongly suggest
that TNBC is sensitive to epigenetic therapies. Therefore, we propose a new strategy to treat …
that TNBC is sensitive to epigenetic therapies. Therefore, we propose a new strategy to treat …
Epigenetic therapy for breast cancer
FF Cai, C Kohler, B Zhang, MH Wang, WJ Chen… - International journal of …, 2011 - mdpi.com
… Epigenetic therapies using the inhibitors of these enzymes have anti-tumorigenic effects on
… on DNA methylation inhibitors and histone deacetylation inhibitors evaluating their potential …
… on DNA methylation inhibitors and histone deacetylation inhibitors evaluating their potential …
Advances in the computational development of DNA methyltransferase inhibitors
JL Medina-Franco, T Caulfield - Drug discovery today, 2011 - Elsevier
… to further advance epigenetic therapies. DNA methylation is an epigenetic change that results
… , a process mediated by DNA methyltransferase enzymes (DNMTs). To date, three types of …
… , a process mediated by DNA methyltransferase enzymes (DNMTs). To date, three types of …
Key actors in cancer therapy: epigenetic modifiers
… epigenetic therapy which has especially focused on DNMT and HDAC inhibitors as enlightened
epigenetic mechanisms in cancer … , is a small molecule of DNA methylation inhibitor. SGI-…
epigenetic mechanisms in cancer … , is a small molecule of DNA methylation inhibitor. SGI-…
Epigenetic modifications as therapeutic targets
… for future epigenetic therapies will be to develop inhibitors with … achieved with DNA
methylation inhibitors, there is still … available DNA methylation inhibitors block DNA methylation …
methylation inhibitors, there is still … available DNA methylation inhibitors block DNA methylation …
Insights into novel emerging epigenetic drugs in myeloid malignancies
NS Chandhok, T Prebet - Therapeutic advances in …, 2019 - journals.sagepub.com
… In this review, we discuss both established and emerging epigenetic therapies in … Alteration
in DNA methylation status is a characteristic epigenetic change in many cancers including …
in DNA methylation status is a characteristic epigenetic change in many cancers including …